First Time Loading...
Y

Yifan Pharmaceutical Co Ltd
SZSE:002019

Watchlist Manager
Yifan Pharmaceutical Co Ltd
SZSE:002019
Watchlist
Price: 13.89 CNY -0.14% Market Closed
Updated: May 21, 2024

Yifan Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yifan Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yifan Pharmaceutical Co Ltd
SZSE:002019
Cost of Revenue
-¥2.4B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
-10%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Cost of Revenue
-¥9.3B
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
-6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-¥1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-¥5.7B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-¥3.8B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-¥28.9B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%

See Also

What is Yifan Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-2.4B CNY

Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Cost of Revenue amounts to -2.4B CNY.

What is Yifan Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%

Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Yifan Pharmaceutical Co Ltd have been 8% over the past three years , 3% over the past five years , and -10% over the past ten years .